A single institutional experience with 43 pregnancies in essential thrombocythemia

European Journal of Haematology

Volumn 66, Issue 3, 2001, Pages 152-159

  Wright, Curtis A ^a   Tefferi, Ayalew ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Chronic myeloproliferative diseases; Essential thrombocythemia; Hemorrhage; Pregnancy; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; APHERESIS; ARTICLE; CLINICAL ARTICLE; ECTOPIC PREGNANCY; FEMALE; FIBRINOLYTIC THERAPY; FIRST TRIMESTER PREGNANCY; HUMAN; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SPONTANEOUS ABORTION; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ABORTION, INDUCED; ABORTION, SPONTANEOUS; ABRUPTIO PLACENTAE; ADULT; ANTICOAGULANTS; ASPIRIN; BUSULFAN; ERYTHROMELALGIA; FEMALE; FETAL DEATH; FOLLOW-UP STUDIES; HEPARIN; HUMANS; HYDROXYUREA; MIGRAINE DISORDERS; OBSTETRIC LABOR, PREMATURE; PHOSPHORUS RADIOISOTOPES; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PLATELETPHERESIS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREGNANCY, ECTOPIC; PREGNANCY, HIGH-RISK; QUINAZOLINES; RETROSPECTIVE STUDIES; RISK; THROMBOCYTHEMIA, HEMORRHAGIC; UTERINE HEMORRHAGE;

EID: 0035062679     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2001.00367.x     Document Type: Article

References (77)

1. Life expectancy of patients with chronic nonleukemic myeloproliferative disorders
2. Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: An Olmsted County Study, 1976-1995
3. 9/1 be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages
4. Epidemiological, diagnostic, therapeutic and prognostic aspects of essential thrombocythemia in a retrospective study of the GIMMC group in two thousand patients
5. Age and sex distributions of hematological malignancies in the UK
6. Acute transformation in nonleukemic chronic myeloproliferative disorders: Actuarial probability and main characteristics in a series of 218 patients
7. Thromboxane-dependent platelet activation in vivo precedes arterial thrombosis in thrombocythaemia: A rationale for the use of low-dose aspirin as an antithrombotic agent
8. Clinical course of essential thrombocythemia in 147 cases
9. Major vascular complications in essential thrombocythemia: A study of the predictive factors in a series of 148 patients
10. Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia
11. No treatment for low-risk thrombocythaemia: Results from a prospective study
12. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis
13. Essential thrombocythemias. Clinical evolutionary and biological data
14. Vascular complications of essential thrombocythaemia: A link to cardiovascular risk factors
15. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: A final report on diagnostic criteria, survival, and leukemic transition by treatment
16. Outcome analysis of 34 pregnancies in women with essential thrombocythemia
17. Primary thrombocythemia and pregnancy: Treatment and outcome in fifteen cases
18. Essential thrombocythemia associated with recurrent abortions and fetal growth retardation
19. Successful pregnancies after recurrent abortions in mild essential thrombocythemia
20. Primary thrombocythaemia in pregnancy
21. Essential thrombocythemia and pregnancy: A report of six normal pregnancies in five untreated patients
22. Clinical manifestations of essential thrombocythemia in young adults
23. Essential thrombocythemia in pregnancy: Platelet count and pregnancy outcome
24. Different outcomes of pregnancy in women with essential thrombocytosis
25. Thrombocythaemia and recurrent late abortions: Normal outcome of pregnancies after antiaggregatory treatment. Case report
26. Three successful pregnancies in a woman with essential thrombocythemia
27. Pregnancy in patients with essential thrombocythemia. Three cases
28. Managing miscarriage
29. Effective measures for the prevention of late abortions and premature births
30. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause
31. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy
32. Thrombosis in pregnancy: Maternal and fetal issues
33. Endocrine factors associated with recurrent spontaneous abortion
34. Recurrent miscarriage: Overview and recommendations
35. Pregnancy loss in the antiphospholipid-antibody syndrome - A possible thrombogenic mechanism
36. Affinity purified human antiphospholipid antibodies bind normal term placenta
37. Platelet-derived growth factor concentrations in platelet-poor plasma and urine from patients with myeloprolifefative disorders
38. Platelet derived growth factor messenger RNA is increased in bone marrow megakaryocytes in patients with myeloproliferative disorders
39. Enhanced expression of cytokines may play a fundamental role in the mechanisms of immunologically mediated recurrent spontaneous abortion
40. Elevated plasma levels of basic fibroblast growth factor in patients with essential thrombocythaemia and polycythaemia vera
41. Recurrent second trimester miscarriage
42. Primary thrombocythemia and myocardial infarction in a 26-yr-old woman with normal coronary arteriogram
43. Thrombocytosis and thrombocythaemia
44. Thrombocythaemia and recurrent miscarriage
45. Idiopathic thrombocythemia and pregnancy: Report of a case
46. Primary thrombocythemia in pregnancy: A report of two cases
47. Postpartum thrombosis in primary thrombocythaemia
48. Essential thrombocythemia and pregnancy
49. Essential thrombocythaemia is not associated with postpartum thrombosis or an increased risk of venous thromboembolism
50. Essential thrombocythemia in young adults
51. Thrombotic complications in essential thrombocythemia with relatively low platelet counts
52. Long-term use of anagrelide in young patients with essential thrombocythemia
53. Treatment of polycythaemia vera and essential thrombocythaemia
54. Essential thrombocythemia in pregnancy
55. Spontaneous remission during two pregnancies in a patient with essential thrombocythaemia
56. Serial serum thrombopoietin levels in a pregnant woman with essential thrombocythaemia
57. Platelet counts during normal pregnancy
58. Platelet levels in pregnancy
59. Pregnancy in a young woman affected by essential thrombocythemia: A case report
60. Idiopathic thrombocythemia and pregnancy; a case report
61. Essential thrombocythemia and complications of pregnancy
62. Treatment of essential thrombocythemia during pregnancy: Antiabortive effect of interferon-alpha?
63. Pregnancy in essential thrombocythemia: Treatment and outcome in 19 cases
64. Cytotoxic therapy and pregnancy
65. Hydroxyurea use during pregnancy: A case report in sickle cell disease and review of the literature
66. Normal pregnancy in a patient with essential thrombocythemia treated with interferon-alpha 2b
67. Alpha 2b-interferon therapy and pregnancy - Report of a case of essential thrombocythemia
68. Successful treatment of essential thrombocythemia with alpha interferon during pregnancy
69. Interferon-alpha 2a treatment in a pregnant woman with essential thrombocythemia
70. Successful treatment of essential thrombocythaemia and recurrent abortion with alpha interferon
71. Childbearing age patients with essential thrombocythemia: Should they be placed on interferon?
72. Treatment of essential thrombocythemia during pregnancy with interferon-alpha
73. Successful treatment of essential thrombocythemia in a pregnancy with recombinant interferon-alpha 2a
74. Platelet counts during pregnancy in essential thrombocythaemia treated with recombinant alpha-interferon
75. Transient normal platelet counts and decreased requirement for interferon during pregnancy in essential thrombocythaemia
76. Essential thrombocythemia during pregnancy
77. Interferon-alpha therapy in polycythemia vera and essential thrombocythemia